Soleno Therapeutics, Inc. (SLNO)
53.01
+0.02
(+0.04%)
USD |
NASDAQ |
May 15, 16:00
53.02
+0.01
(+0.02%)
After-Hours: 20:00
Soleno Therapeutics Market Cap : 2.763B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Neurocrine Biosciences, Inc. | 15.93B |
| Nektar Therapeutics | 1.222B |
| XOMA Royalty Corp. | 523.59M |
| Apellis Pharmaceuticals, Inc. | 5.253B |
| Forian, Inc. | 67.79M |
Market Cap Related Metrics
| PE Ratio | 30.09 |
| PS Ratio | 9.895 |
| Price to Book Value | 5.573 |
| Price to Free Cash Flow | 26.75 |
| Price | 53.01 |
| Earnings Yield | 3.32% |
| Operating PE Ratio | 31.51 |
| Normalized PE Ratio | 29.41 |